Cite
HARVARD Citation
Yu, J. et al. (2019). Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir. European journal of gastroenterology & hepatology. 31 (7), p. . [Online].